165 related articles for article (PubMed ID: 11016724)
21. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?
McMasters KM; Reintgen DS; Ross MI; Wong SL; Gershenwald JE; Krag DN; Noyes RD; Viar V; Cerrito PB; Edwards MJ
Ann Surg Oncol; 2001 Apr; 8(3):192-7. PubMed ID: 11314933
[TBL] [Abstract][Full Text] [Related]
22. Validation of gamma probe detection of the sentinel node in melanoma.
Kapteijn BA; Nieweg OE; Muller SH; Liem IH; Hoefnagel CA; Rutgers EJ; Kroon BB
J Nucl Med; 1997 Mar; 38(3):362-6. PubMed ID: 9074518
[TBL] [Abstract][Full Text] [Related]
23. Sentinel node biopsy in clinical stage 1 melanoma: rationale for restaging and follow-up.
Mazzuca N; Bagnoni G; Solimeo C; Malvaldi F; Pratali R; Ceccarini M; Santini P; Morini V
Tumori; 2000; 86(4):351-3. PubMed ID: 11016727
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node dissection for primary cutaneous melanoma: a community hospital's initial experience.
Habib FA; Lodish ME; Mittal VK; Young SC
Am Surg; 2000 Mar; 66(3):291-5. PubMed ID: 10759202
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy in melanoma of the head and neck.
Wells KE; Rapaport DP; Cruse CW; Payne W; Albertini J; Berman C; Lyman GH; Reintgen DS
Plast Reconstr Surg; 1997 Sep; 100(3):591-4. PubMed ID: 9283554
[TBL] [Abstract][Full Text] [Related]
26. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of sentinel lymph node in malignant melanoma: preoperative lymphoscintigraphy and intraoperative gamma probe guidance].
Dresel S; Weiss M; Heckmann M; Rossmüller B; Konz B; Tatsch K; Hahn K
Nuklearmedizin; 1998 Aug; 37(5):177-82. PubMed ID: 9728345
[TBL] [Abstract][Full Text] [Related]
28. The role of interval nodes in sentinel lymph node mapping and dissection for melanoma patients.
Matter M; Nicod Lalonde M; Allaoua M; Boubaker A; Liénard D; Gugerli O; Cerottini JP; Bouzourene H; Bischof Delaloye A; Lejeune F
J Nucl Med; 2007 Oct; 48(10):1607-13. PubMed ID: 17873127
[TBL] [Abstract][Full Text] [Related]
29. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance.
Pijpers R; Borgstein PJ; Meijer S; Hoekstra OS; van Hattum LH; Teule GJ
World J Surg; 1997 Oct; 21(8):788-92; discussion 793. PubMed ID: 9327667
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node mapping for malignant melanoma.
Landra M; Acchiardi F; Pugno F; Forte G; Granetto C; Camuzzini GF
Tumori; 2000; 86(4):354-5. PubMed ID: 11016728
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node biopsy for malignant melanoma: analysis of a four-year experience.
Caggiati A; Potenza C; Gabrielli F; Passarelli F; Tartaglione G
Tumori; 2000; 86(4):332-5. PubMed ID: 11016720
[TBL] [Abstract][Full Text] [Related]
32. Sentinel node biopsy in cutaneous melanoma patients: technical and clinical aspects.
Casara D; Rubello D; Rossi CR; Scagnet B; Mocellin S; Pilati P; Foletto M; Montesco MC; Tregnaghi A; Rubaltelli L; Lise M
Tumori; 2000; 86(4):339-40. PubMed ID: 11016722
[TBL] [Abstract][Full Text] [Related]
33. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
Villa G; Gipponi M; Buffoni F; Vecchio C; Bianchi P; Agnese G; Di Somma C; Catturich A; Rosato F; Tomei D; Nicolò G; Badellino F; Mariani G; Canavese G
Tumori; 2000; 86(4):297-9. PubMed ID: 11016707
[TBL] [Abstract][Full Text] [Related]
34. Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas.
Maccauro M; Villano C; Aliberti G; Ferrari L; Castellani MR; Patuzzo R; Tshering D; Santinami M; Bombardieri E
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):245-51. PubMed ID: 16172570
[TBL] [Abstract][Full Text] [Related]
35. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study.
Maza S; Valencia R; Geworski L; Sandrock D; Zander A; Audring H; Dräger E; Winter H; Sterry W; Munz DL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):538-44. PubMed ID: 12582814
[TBL] [Abstract][Full Text] [Related]
36. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye.
Kapteijn BA; Nieweg OE; Liem I; Mooi WJ; Balm AJ; Muller SH; Peterse JL; Valdés Olmos RA; Hoefnagel CA; Kroon BB
Ann Surg Oncol; 1997 Mar; 4(2):156-60. PubMed ID: 9084853
[TBL] [Abstract][Full Text] [Related]
37. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
38. Penile lymphoscintigraphy for sentinel node identification.
Valdés Olmos RA; Tanis PJ; Hoefnagel CA; Jansen L; Nieweg OE; Meinhardt W; Horenblas S
Eur J Nucl Med; 2001 May; 28(5):581-5. PubMed ID: 11383862
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node study in early breast cancer.
Feggi LM; Querzoli P; Prandini N; Corcione S; Bergossi L; Basaglia E; Carcoforo P
Tumori; 2000; 86(4):314-6. PubMed ID: 11016713
[TBL] [Abstract][Full Text] [Related]
40. [Sentinel lymph node identification in the staging of cutaneous melanoma. Blue dye vs. radioguided localization].
Gesuelli GC; Sartelli M; Berbellini A; Brianzoni E; Simonacci M; Sigona M
Minerva Chir; 2000; 55(7-8):513-6. PubMed ID: 11140105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
